The Alongshan virus was discovered in China only five years ago. Now researchers at the University of Zurich have found the novel virus for the first time in Swiss ticks. It appears to be at least as widespread as the tickborne ...
Dec 7, 2022
0
91
Shehzin Tietjen was 27 years old when she felt a lump in one of her breasts while in the shower.
Dec 6, 2022
0
2
Scientists from the National University of (NUS) have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, this new test sequences clinical samples that have been heated in order to isolate ...
Dec 5, 2022
0
133
Women with prolonged mental health problems up to three years after childbirth may be suffering from irregular immune system responses, according to new research by Cedars-Sinai investigators. The findings are published in ...
Dec 2, 2022
0
71
An international team of scientists led by Mass Eye and Ear, a member of Mass General Brigham, and Boston Children's Hospital, has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, ...
Dec 1, 2022
0
10
Nine in 10 Australians would participate in preventive DNA screening for risk of medically actionable conditions, a new national survey has found.
Dec 1, 2022
0
2
Genetic testing in patients with epilepsy can inform treatment and lead to better outcomes in many cases, according to a new study published in JAMA Neurology.
Nov 30, 2022
0
42
A family history of cancer and genetic variants that might be inherited appear to be important risk factors for Black men diagnosed with early-onset prostate cancer, a study involving Duke Health researchers has found.
Nov 29, 2022
0
0
The field of genomic science is rapidly advancing, with commercial genetic tests becoming affordable and popular.
Nov 29, 2022
0
3
More than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the disease remain unexplored for the majority of patients around the world. In the final days of the Movember ...
Nov 28, 2022
0
2
